JPM
JPMorgan Chase & Co.
JPM's fundamentals are strong, but it looks expensive: trading at 14x earnings, above its usual 12x. Analysts expect earnings growth.
RYAN
Ryan Specialty Holdings, Inc.
There isn't enough reported data to score RYAN yet.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
RYAN Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Stable | |
| N/A | |
| N/A |
RYAN's profitability is currently stable. There isn't enough data to rate its revenue. Free cash flow and net leverage aren't meaningful measures for financial services companies like RYAN.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM's PE is in its expensive range at 14.4x. If earnings grow as analysts expect, today's price would be 13.7x next year's earnings.
RYAN PE Valuation
RYAN has no meaningful PE right now: it lost money over the past year.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
RYAN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Growth | |
| Growth | |
| Improving | |
| Moderate | |
| High |
Analysts expect earnings and revenue growth for RYAN, with profitability improving.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the stronger earnings trend. Trailing diluted EPS is up 18% for JPM versus RYAN down 71%.
RYAN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.35 | +2037% |
| Q4 2025 | $0.11 | -71% |
| Q3 2025 | $0.13 | -75% |
| Q2 2025 | $0.12 | -68% |
| Q1 2025 | $0.10 | -78% |
| Q4 2024 | $0.38 | -45% |
| Q3 2024 | $0.51 | -24% |
| Q2 2024 | $0.37 | -55% |
| Q1 2024 | $0.46 | -41% |
RYAN's earnings per share have fallen from their peak: $0.11 over the past year, against $0.82 in mid-2023.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
RYAN has the stronger quarterly revenue trend. Revenue is up 8.1% for JPM versus up 14% for RYAN.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over RYAN on profitability, with a higher operating margin.
RYAN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $790M | +4.7% |
| Q4 2025 | $751.2M | +13% |
| Q3 2025 | $754.6M | +25% |
| Q2 2025 | $855.2M | +23% |
| Q1 2025 | $690.2M | +25% |
| Q4 2024 | $663.5M | +25% |
| Q3 2024 | $604.7M | +20% |
| Q2 2024 | $695.4M | +19% |
RYAN's revenue has grown year over year every quarter since early 2021: $790M last quarter, up 14% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 18% | -2.8 points |
| Q4 2025 | 18% | +7.6 points |
| Q3 2025 | 21% | +17 points |
| Q2 2025 | 16% | -3.6 points |
| Q1 2025 | 7.4% | -1.1 points |
| Q4 2024 | 10% | -0.7 points |
| Q3 2024 | 3.3% | -4.8 points |
| Q2 2024 | 20% | +3.4 points |
RYAN's operating margin was 18% last quarter, up 10 points from the same quarter a year ago.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
RYAN has the stronger cash trend. Its trailing FCF is up 176% versus its history, compared with JPM at down 229%.
RYAN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $181.3M | +17% |
| Q4 2025 | $246M | +1.5% |
| Q3 2025 | $155.5M | +66% |
| Q2 2025 | $333.8M | +30% |
| Q1 2025 | -$159.6M | -$35.4M |
| Q4 2024 | $242.3M | +14% |
| Q3 2024 | $93.8M | -1.1% |
| Q2 2024 | $255.9M | -15% |
RYAN's free cash flow was $917M over the past year, up 112% from the year before. Free cash flow isn't a meaningful measure for financial services companies like RYAN.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over RYAN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
RYAN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -9.7% | -26.9M shares |
| 1 year | +100% | +126M shares |
| 3 years | +127% | +141M shares |
| 5 years | +136% | +145M shares |
RYAN has 252M diluted shares, up 100% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $150.1M |
| Q4 2025 | $3.5M |
| Q3 2025 | $82,000 |
| Q2 2025 | $13M |
| Q1 2025 | $1.7M |
| Q4 2024 | $83,000 |
| Q3 2024 | $82,000 |
| Q2 2024 | — |
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
RYAN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2025 | 4.2x | High |
| Q3 2025 | 4.2x | High |
| Q2 2025 | 4.8x | High |
| Q1 2025 | 5.5x | High |
| Q4 2024 | 4.9x | High |
| Q3 2024 | 4.9x | High |
| Q2 2024 | 2.9x | Moderate |
| Q1 2024 | 3.1x | Elevated |
RYAN's net debt is about 4.2 years of its operating earnings (EBITDA), down from 4.9 years a year ago. Net leverage isn't a meaningful measure for financial services companies like RYAN.
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
RYAN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 59.4 | Neutral |
| Stochastic | 78.4 | Neutral |
RYAN's weekly RSI is 59 (neutral) and its Stochastic is 78 (neutral).
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
RYAN PE vs Financial Services Sector
| Metric | RYAN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
RYAN has no meaningful PE right now: it lost money over the past year.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM has the edge over RYAN on trend strength, trading above more of its moving averages.
RYAN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $41.8 | 10% above |
| 20 week MA | $41.9 | 10% above |
| 50 week MA | $41.0 | 12% above |
| 100 week MA | $52.3 | 12% below |
| 200 week MA | $51.7 | 11% below |
RYAN has bounced recently, but its long-term trend is still down: it's above its 8-, 20- and 50-week averages, but 11% below its 200-week average.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has the edge over RYAN on returns for 2026, with the stronger performance.
RYAN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $28.6 | $39.3 | +38% |
| 2022 | $39.3 | $40.6 | +3.1% |
| 2023 | $40.6 | $43.0 | +6.1% |
| 2024 | $43.0 | $64.0 | +49% |
| 2025 | $64.0 | $51.8 | -19% |
| 2026 YTD | $51.8 | $46.2 | -11% |
RYAN has finished higher in four of the last five years. It's down 11% so far in 2026.